Here are five things to know:
1. Presently, the firm has a “buy” rating on AmSurg shares.
2. The analysts’ updated price target indicates a 20.68 percent potential upside from AmSurg’s current price.
3. Last Wednesday, AmSurg shares hit $74.58, down 1.92 percent.
4. AmSurg has a 50-day moving average of $76.93 and 200-day moving average of $74.82.
5. The market cap is $4.01 billion.
More articles on surgery centers:
St. Elizabeth Healthcare to testify against Christ Hospital’s $24M ASC: 7 key points
BCBS of Texas requests 60% price hike: 5 takeaways
Will IRS’ latest ruling compromise ACOs’ sustainability? 4 highlights
